Complete Up To Date Information about Imizol .
NADA Number: 141-071 | |
| Proprietary Name |
Imizol® |
|---|---|
| Sponsor |
Schering-Plough Animal Health Corp. |
| Sponsor Address |
P.O. Box 21 Sandown Village, NJ 3171 VIC Australia |
| Ingredients |
Imidocarb Dipropionate |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Intramuscular Subcutaneous |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Exclusivity |
Granted for the treatment of dogs with clinical signs of babesiosis and/or demonstrated Babesia organisms in the blood. |
|
Dosage Amount, Indications & Limitations |
522.1156 Imidocarb dipropionate solution. Specifications: Each milliliter of injectable solution contains120 milligrams of imidocarb. Conditions of use: Dogs Amount: 6.6 milligrams imidocarb per kilogram (3 milligrams per pound) of body weight. Use subcutaneously or intramuscularly. Indications: Treatment of clinical signs of babesiosis and/or demonstrated Babesia organisms in the blood. Limitations: Not for intravenous use. Repeat the dose after 2 weeks for a total of two treatments. Imidocarb is a cholinesterase inhibitor. Do not use simultaneously with or a few days before or after treatment with or exposure to cholinesterase-inhibiting drugs, pesticides, or chemicals. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |